Global Cannabis Applications’ Brad Moore on the impact of artificial intelligence in the medicinal marijuana market
We use different forms of artificial intelligence to actually come up with a product of data that dispensary workers, LPs, and retailers can use to create better prescriptions so that when you go home you have more confidence that certain products can help you with your glaucoma or your arthritis or whatever ailment that you are suffering from.” states Brad Moore, CEO and Director of
Global Cannabis Applications Corp. (CSE: C.APP,OTCQB: FUAPF,Forum), in an interview with InvestorIntel’s Peter Clausi.
FULL DISCLOSURE: Global Cannabis Applications Corp. is a paid client of Stockhouse Publishing.